WuXi AppTec Co., Ltd. (603259.SS)
CNY 56.22
(3.06%)
CNY 56.22
(3.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.66 Billion CNY | -0.54% |
| 2022 | 17.76 Billion CNY | 8.51% |
| 2021 | 16.36 Billion CNY | 20.61% |
| 2020 | 13.57 Billion CNY | 14.74% |
| 2019 | 11.82 Billion CNY | 162.76% |
| 2018 | 4.5 Billion CNY | -22.94% |
| 2017 | 5.84 Billion CNY | 29.02% |
| 2016 | 4.52 Billion CNY | 39.06% |
| 2015 | 3.25 Billion CNY | 22.44% |
| 2014 | 2.65 Billion CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 18.89 Billion CNY | 6.92% |
| 2024 Q3 | 18.65 Billion CNY | 2.18% |
| 2024 Q2 | 18.25 Billion CNY | -3.36% |
| 2023 FY | 17.66 Billion CNY | -0.54% |
| 2023 Q1 | 18.35 Billion CNY | 3.34% |
| 2023 Q3 | 19.77 Billion CNY | 3.4% |
| 2023 Q4 | 17.66 Billion CNY | -10.64% |
| 2023 Q2 | 19.12 Billion CNY | 4.16% |
| 2022 FY | 17.76 Billion CNY | 8.51% |
| 2022 Q4 | 17.76 Billion CNY | -13.82% |
| 2022 Q3 | 20.61 Billion CNY | 5.59% |
| 2022 Q2 | 19.52 Billion CNY | 15.26% |
| 2022 Q1 | 16.93 Billion CNY | 3.45% |
| 2021 FY | 16.36 Billion CNY | 20.61% |
| 2021 Q4 | 16.36 Billion CNY | 5.38% |
| 2021 Q1 | 13.08 Billion CNY | -3.59% |
| 2021 Q2 | 15.19 Billion CNY | 16.12% |
| 2021 Q3 | 15.53 Billion CNY | 2.24% |
| 2020 Q4 | 13.57 Billion CNY | 9.19% |
| 2020 Q3 | 12.43 Billion CNY | 1.7% |
| 2020 Q2 | 12.22 Billion CNY | -1.28% |
| 2020 Q1 | 12.38 Billion CNY | 4.66% |
| 2020 FY | 13.57 Billion CNY | 14.74% |
| 2019 Q1 | 4.87 Billion CNY | 8.31% |
| 2019 Q3 | 10.05 Billion CNY | 59.67% |
| 2019 Q4 | 11.82 Billion CNY | 17.61% |
| 2019 FY | 11.82 Billion CNY | 162.76% |
| 2019 Q2 | 6.29 Billion CNY | 29.19% |
| 2018 Q1 | 5.64 Billion CNY | -3.41% |
| 2018 Q4 | 4.5 Billion CNY | -26.56% |
| 2018 Q3 | 6.13 Billion CNY | 5.58% |
| 2018 Q2 | 5.8 Billion CNY | 2.89% |
| 2018 FY | 4.5 Billion CNY | -22.94% |
| 2017 Q1 | 3.95 Billion CNY | 0.0% |
| 2017 Q3 | 5.38 Billion CNY | 0.0% |
| 2017 Q4 | 5.84 Billion CNY | 8.51% |
| 2017 FY | 5.84 Billion CNY | 29.02% |
| 2016 FY | 4.52 Billion CNY | 39.06% |
| 2015 FY | 3.25 Billion CNY | 22.44% |
| 2014 FY | 2.65 Billion CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 8.84 Billion CNY | -99.755% |
| Joinn Laboratories(China)Co.,Ltd. | 1.67 Billion CNY | -956.943% |
| Autobio Diagnostics Co., Ltd. | 2.85 Billion CNY | -518.473% |
| Thalys Medical Technology Group Inc. | 2.02 Billion CNY | -771.603% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 3.19 Billion CNY | -452.942% |
| Chemclin Diagnostics Co., Ltd. | 431.76 Million CNY | -3992.127% |